Molecular imaging using PET for breast cancer

被引：17

作者：

Kurihara, Hiroaki ^{[1
]}

Shimizu, Chikako ^{[2
]}

Miyakita, Yasuji ^{[3
]}

Yoshida, Masayuki ^{[4
]}

Hamada, Akinobu ^{[5
]}

Kanayama, Yousuke ^{[6
]}

Yonemori, Kan ^{[2
]}

Hashimoto, Jun ^{[2
]}

Tani, Hitomi ^{[1
]}

Kodaira, Makoto ^{[2
]}

Yunokawa, Mayu ^{[2
]}

Yamamoto, Harukaze ^{[2
]}

Watanabe, Yasuyoshi ^{[6
]}

Fujiwara, Yasuhiro ^{[2
]}

Tamura, Kenji ^{[2
]}

机构：

[1] Natl Canc Ctr, Dept Diagnost Radiol, Chuo Ku, Tokyo 1040045, Japan

[2] Natl Canc Ctr, Dept Breast & Med Oncol, Tokyo 1040045, Japan

[3] Natl Canc Ctr, Dept Neurosurg, Tokyo 1040045, Japan

[4] Natl Canc Ctr, Dept Pathol & Clin Labs, Tokyo 1040045, Japan

[5] Natl Canc Ctr, Res Inst, Dept Clin Pharmacol Grp, Translat Res Support Core, Tokyo 104, Japan

[6] RIKEN, Ctr Mol Imaging Sci, Kobe, Hyogo, Japan

来源：

BREAST CANCER | 2016年 / 23卷 / 01期

关键词：

Breast cancer; PET; Molecular imaging; Molecular target therapy; HER2; POSITRON-EMISSION-TOMOGRAPHY; ESTROGEN-RECEPTOR; FDG-PET; WHOLE-BODY; NEOADJUVANT CHEMOTHERAPY; ADJUVANT CHEMOTHERAPY; F-18-FDG PET; TRASTUZUMAB; TUMOR; EXPRESSION;

D O I：

10.1007/s12282-015-0613-z

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Molecular imaging can visualize the biological processes at the molecular and cellular levels in vivo using certain tracers for specific molecular targets. Molecular imaging of breast cancer can be performed with various imaging modalities, however, positron emission tomography (PET) is a sensitive and non-invasive molecular imaging technology and this review will focus on PET molecular imaging of breast cancer, such as FDG-PET, FLT-PET, hormone receptor PET, and anti-HER2 PET.

引用

页码：24 / 32

页数：9

共 80 条

[31] Imaging early changes in proliferation at 1 week post chemotherapy:: a pilot study in breast cancer patients with 3′-deoxy-3′-[18F]fluorothymidine positron emission tomography [J].

Kenny, Laura ;

Coombes, R. Charles ;

Vigushin, David M. ;

Al-Nahhas, Adil ;

Shousha, Sami ;

Aboagye, Eric O. .

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 (09) :1339-1347

[32] Altered Tissue 3′-Deoxy-3′-[18F]Fluorothymidine Pharmacokinetics in Human Breast Cancer following Capecitabine Treatment Detected by Positron Emission Tomography [J].

Kenny, Laura M. ;

Contractor, Kaiyumars B. ;

Stebbing, Justin ;

Ai-Nahhas, Adil ;

Palmieri, Carlo ;

Shousha, Sami ;

Coombes, R. Charles ;

Aboagye, Eric O. .

CLINICAL CANCER RESEARCH, 2009, 15 (21) :6649-6657

[33] Comparison of 18F-fluoromethylcholine and 2-deoxy-D-glucose in the distribution of tumor and inflammation [J].

Kubota, Kazuo ;

Furumoto, Shozo ;

Iwata, Ren ;

Fukuda, Hiroshi ;

Kawamura, Kazunori ;

Ishiwata, Kiichi .

ANNALS OF NUCLEAR MEDICINE, 2006, 20 (08) :527-533

[34]

Kurihara H, 2015, EJNMMI RES IN PRESS

[35] Loss of estrogen receptor in recurrent breast cancer is associated with poor response to endocrine therapy [J].

Kuukasjarvi, T ;

Kononen, J ;

Helin, H ;

Holli, K ;

Isola, J .

JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (09) :2584-2589

[36] Reliability of Human Epidermal Growth Factor Receptor 2 Immunohistochemistry in Breast Core Needle Biopsies [J].

Lebeau, Annette ;

Turzynski, Andreas ;

Braun, Susanne ;

Behrhof, Wera ;

Fleige, Barbara ;

Schmitt, Wolfgang D. ;

Grob, Tobias J. ;

Burkhardt, Lia ;

Hoelzel, Dieter ;

Jackisch, Christian ;

Thomssen, Christoph ;

Mueller, Volkmar ;

Untch, Michael .

JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (20) :3264-3270

[37] Development of [F-18]Fluorine-Substituted Tanaproget as a Progesterone Receptor Imaging Agent for Positron Emission Tomography [J].

Lee, Jae Hak ;

Zhou, Hai-bing ;

Dence, Carmen S. ;

Carlson, Kathryn E. ;

Welch, Michael J. ;

Katzenellenbogen, John A. .

BIOCONJUGATE CHEMISTRY, 2010, 21 (06) :1096-1104

[38] The Role of MRI in Breast Cancer Screening [J].

Lehman, Constance D. ;

Smith, Robert A. .

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2009, 7 (10) :1109-1115

[39] Quantitative fluoroestradiol positron emission tomography imaging predicts response to endocrine treatment in breast cancer [J].

Linden, Hannah M. ;

Stekhova, Svetlana A. ;

Link, Jeanne M. ;

Gralow, Julie R. ;

Livingston, Robert B. ;

Ellis, Georgiana K. ;

Petra, Philip H. ;

Peterson, Lanell M. ;

Schubert, Erin K. ;

Dunnwald, Lisa K. ;

Krohn, Kenneth A. ;

Mankoff, David A. .

JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) :2793-2799

[40] PET/CT-Derived Whole-Body and Bone Marrow Dosimetry of 89Zr-Cetuximab [J].

Makris, Nikolaos E. ;

Boellaard, Ronald ;

van Lingen, Arthur ;

Lammertsma, Adriaan A. ;

van Dongen, Guus A. M. S. ;

Verheul, Henk M. ;

Menke, Catharina W. ;

Huisman, Marc C. .

JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (02) :249-254

← 1 2 3 4 5 6 7 8 →